Page 155 - Evelop News Today

KATY, TX / ACCESSWIRE / June 3, 2021 / Neutra Corp. (OTC PINK:NTRR) is looking into expanding into clinical research as a way to figure out new uses for cannabis, boost its capabilities and come up with

GoI and British science museum group to organise travelling ANI 04 Jun 2021, 00:27 GMT+10 New Delhi [India], June 3 (ANI): National Council of Science Museums (NCSM) and Science Museum Group, London will jointly organise a travelling exhibition to tell the story of global efforts to develop COVID-19 vaccines. The exhibition that covers Indias metropolitan cities will be inaugurated in November 2022 in Delhi, a release of Ministry of Culture said. "National Council of Science Museums (NCSM), an ...

Edible Cosmetic Market to Develop New Growth Story | LUSH Cosmetics, Tarte Cosmetics, Bite Beauty

BEIJING (dpa-AFX) - Vehicle engine manufacturer China Yuchai International Ltd. (CYD) announced Wednesday that it has entered into a strategic partnership agreement with an electric vehicle or

Accounts Receivable Software Market to Develop New Growth Story | Armatic, Open Systems, HighRadius

Datasea Inc.: Datasea Announces Its Engagement By ZTO Express to Develop 5G Messaging Applications BEIJING, CHINA / ACCESSWIRE / June 1, 2021 / Datasea Inc. (NASDAQ:DTSS) (" Datasea "), a technology company engaged in providing smart security solutions, smart hardware and education- related technologies in China, announced today that its wholly-owned subsidiary company named Shuhai Zhangxun Information Technology Co., Ltd. ("Shuhai Zhangxun") obtained authorization from ZTO Express ("ZTO"), one...

Atos International: Atos successfully delivers command system for the SCORPION program to the French Defense Procurement Agency and signs major contract to further develop solution SCORPION program , to the French Defense Procurement Agency (Direction Générale de lArmement, DGA). Additionally, the DGA has also entrusted Atos to further develop the system and maintain it in working condition. This information system has a provisional authorization to operate at the "Restricted Distribution" le...

Vancouver, British Columbia--(Newsfile Corp. - June 1, 2021) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") is pleased to announce today that its wholly-owned subsidiary

TERRE HAUTE, Ind., June 01, 2021 (GLOBE NEWSWIRE) Hallador Energy Company (NASDAQ HNRG) announced today it will join with Hoosier Energy Rural Electric ...

Amgen, Kyowa Kirin To Jointly Develop, Commercialize KHK4083 THOUSAND OAKS (dpa-AFX) - Amgen (AMGN) announced an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, an anti-OX40 fully human monoclonal antibody. KHK4083 is Kyowa Kirins potential first-in-class, Phase 3-ready anti-OX40 fully human monoclonal antibody in development for the treatment of atopic dermatitis, with potential in other autoimmune diseases. As per the terms of the deal, Amgen will make a $40...